About BioNeex
BioNeex is a Healthcare company based in Berlin (Germany) founded in 2018 by Smbat Rafayelyan and Tigran Rafayelyan. SaaS platform for biopharma drug licensing and partnerships is provided. BioNeex has raised $500 thousand across 1 funding round. Its chief executive, as recorded, is Smbat Rafayelyan. Its focus areas include HealthTech, Life Sciences Tech, Business Development and Professional Networks. Its legal entity is BioNeex UG.
Company details
BioNeex was founded in 2018 in Berlin, Germany, as a provider of SaaS-based solutions for the biopharma sector. An RD exchange platform is offered, enabling searches for drug candidates, pipelines, and market trend insights. Drug licensing and partnership opportunities are facilitated through this digital exchange, supporting biopharma companies in identifying and collaborating on development projects across the industry.
- Headquarters Berlin, Germany
- Founders Smbat Rafayelyan, Tigran Rafayelyan
- SectorsHealthcare
- Email••••••••
- Website bioneex.com
- Social LinkedIn X
- Legal Name Bioneex Ug
- Total Equity Funding$500K (USD)
in 1 rounds
- Latest Funding Round$500K (USD), Seed
Feb 2024
Funding Insights of BioNeex
BioNeex has successfully raised a total of $500K through 1 strategic funding round. The most recent funding activity was a Seed round of $500 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 1
- Last Round Seed — $500,000
- First Round $500,000
(Feb 2024)
All 1 funding rounds of BioNeex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $500,000 | Seed | – | – | – |
People of BioNeex
2 people are tracked at BioNeex (2 in leadership).
| Name | Role | Group |
|---|---|---|
Smbat Rafayelyan | Founder & CEO | Leadership |
Tigran Rafayelyan | Co-Founder & CTO | Leadership |
Complete people profiles for BioNeex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioNeex
2 dated milestones of BioNeex across 6 years, from founding to its latest funding, stage changes and deals.
- Founded BioNeex is founded.
- Funding First funding round of $500K.
Web traffic of BioNeex
The website of BioNeex (bioneex.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 136.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioneex
Complete news archive for BioNeex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioNeex
BioNeex was founded in 2018 and raised its 1st funding round 6 years after it was founded.
BioNeex is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Smbat Rafayelyan is the CEO of BioNeex, as recorded in our data. They have also founded this company.
BioNeex is a funded company, having raised a total of $500K across 1 funding round to date. The company's 1st funding round was a Seed of $500K, raised on Feb 2024.
BioNeex was founded in 2018 in Berlin, Germany, as a provider of SaaS-based solutions for the biopharma sector. An RD exchange platform is offered, enabling searches for drug candidates, pipelines, and market trend insights. Drug licensing and partnership opportunities are facilitated through this digital exchange, supporting biopharma companies in identifying and collaborating on development projects across the industry.
BioNeex operates through Bioneex Ug.